Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Neoplasms 3Colorectal Neoplasms 3Appendiceal Neoplasms 3Anus Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Liver Neoplasms 2Carcinoma, Hepatocellular 2Uterine Neoplasms 1Urothelial Carcinoma Ureter 1Unspecified Adult Solid Tumor, Protocol Specific 1Solid Neoplasm 1Peritoneal Diseases 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasm Metastasis 1Necrosis 1Lung Metastases 1Leukemia, Myeloid, Acute 1Leukemia 1Gastrointestinal Neoplasms 1Dermatitis 1

Interventions

Mitomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Peritoneal Diseases × Mitomycin × Clear all
NCT07487168 2026-05-15

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Not yet recruiting
24 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡